Alzheimer's disease: Transgenic mouse models and drug assessment

Authors
Citation
P. Yu et G. Oberto, Alzheimer's disease: Transgenic mouse models and drug assessment, PHARMAC RES, 42(2), 2000, pp. 107-114
Citations number
92
Categorie Soggetti
Pharmacology & Toxicology
Journal title
PHARMACOLOGICAL RESEARCH
ISSN journal
10436618 → ACNP
Volume
42
Issue
2
Year of publication
2000
Pages
107 - 114
Database
ISI
SICI code
1043-6618(200008)42:2<107:ADTMMA>2.0.ZU;2-T
Abstract
Alzheimer's disease (AD), characterized by neuritic plaques and neurofibril lary tangles of the brain, is experienced by more and more elderly people i n a form of senile dementia. Four genes are closely linked with AD and are located on chromosomes 21, 19, 14 and 1. Transgenic technology enables the development of animal models for research into this human disease. Recently reported transgenic AD mouse models, which express AD-related mutant human genes, develop some significant aspects of AD-like pathology. The specific role of these mice in representing different targets, the consequent patho logy of AD and the availability of this increasingly popular tool for inves tigating new therapeutic strategies for AD are reviewed. (C) 2000 Academic Press.